Amylyx Pharmaceuticals Inc (AMLX)
NASDAQ:AMLX
US Market

Amylyx Pharmaceuticals Inc (AMLX) Stock Price & Analysis

147 Followers

AMLX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$17.80 - $41.93
Previous Close$18.72
Volume1.18M
Average Volume (3M)1.13M
Market Cap
$1.25B
Enterprise ValueN/A
Total Cash (Recent Filing)$357.28M
Total Debt (Recent Filing)$5.29M
Price to Earnings (P/E)-15.2
Beta0.86
Nov 09, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.23
Shares Outstanding67,377,743
10 Day Avg. Volume1,197,264
30 Day Avg. Volume1,132,421
Standard Deviation0.36
R-Squared0.02
Alpha0.05
Financial Highlights & Ratios
Price to Book (P/B)3.22
Price to Sales (P/S)12.84
Price to Cash Flow (P/CF)36.20
P/FCF Ratio37.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
Price Target Upside152.53% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4


Financials

Annual

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.

---

AMLX FAQ

What was Amylyx Pharmaceuticals Inc’s price range in the past 12 months?
Amylyx Pharmaceuticals Inc lowest stock price was $17.80 and its highest was $41.93 in the past 12 months.
    What is Amylyx Pharmaceuticals Inc’s market cap?
    Currently, no data Available
    When is Amylyx Pharmaceuticals Inc’s upcoming earnings report date?
    Amylyx Pharmaceuticals Inc’s upcoming earnings report date is Nov 09, 2023 which is in 43 days.
      How were Amylyx Pharmaceuticals Inc’s earnings last quarter?
      Amylyx Pharmaceuticals Inc released its earnings results on Aug 10, 2023. The company reported $0.31 earnings per share for the quarter, beating the consensus estimate of $0.19 by $0.12.
        Is Amylyx Pharmaceuticals Inc overvalued?
        According to Wall Street analysts Amylyx Pharmaceuticals Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Amylyx Pharmaceuticals Inc pay dividends?
          Amylyx Pharmaceuticals Inc does not currently pay dividends.
          What is Amylyx Pharmaceuticals Inc’s EPS estimate?
          Amylyx Pharmaceuticals Inc’s EPS estimate is $0.46.
            How many shares outstanding does Amylyx Pharmaceuticals Inc have?
            Amylyx Pharmaceuticals Inc has 67,377,750 shares outstanding.
              What happened to Amylyx Pharmaceuticals Inc’s price movement after its last earnings report?
              Amylyx Pharmaceuticals Inc reported an EPS of $0.31 in its last earnings report, beating expectations of $0.19. Following the earnings report the stock price went up 2.031%.
                Which hedge fund is a major shareholder of Amylyx Pharmaceuticals Inc?
                Among the largest hedge funds holding Amylyx Pharmaceuticals Inc’s share is Perceptive Advisors LLC. It holds Amylyx Pharmaceuticals Inc’s shares valued at 105M.

                  ---

                  Amylyx Pharmaceuticals Inc Stock Smart Score

                  The Amylyx Pharmaceuticals Inc stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Amylyx Pharmaceuticals Inc

                  Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases.

                  ---

                  Top 5 ETFs holding AMLX

                  Name
                  Market Value
                  Smart Score
                  Vanguard Total Stock Market ETF
                  $35.76M
                  8
                  Vanguard Health Care ETF
                  $2.24M
                  8
                  Fidelity Nasdaq Composite Index ETF
                  $561.67K
                  8
                  Schwab U.S. Broad Market ETF
                  $394.85K
                  8
                  Vanguard Russell 3000 ETF
                  $68.43K
                  8
                  Up to five ETFs with an Outperform Smart Score that hold AMLX. The ETFs are listed according to market value of AMLX within the ETF

                  Forecast EPS vs Actual EPS


                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Amarin
                  Amneal Pharmaceuticals
                  Amgen
                  Veracyte

                  Popular Stocks

                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis